SAN FRANCISCO — The risk for hyperglycemia in hospitalized patients treated with gatifloxacin or levofloxacin increased 112-fold if the patients were diabetic and 10-fold if the dosage was too high for their kidneys to handle, John F. Mohr, Pharm.D., reported at the annual Interscience Conference on Antimicrobial Agents and Chemotherapy.
PREVIEW